Transcenta Announces the Publication of Preclinical Results of [177Lu]Lu-TST001 Radionuclide Antibody Conjugate as Potential Novel Treatment Option for Metastatic Gastric Cancer in the European Journal of Nuclear Medicine and Molecular Imaging

PRINCETON, N.J. and SUZHOU, China, Dec. 13, 2023 /PRNewswire/ — Transcenta Holding…

Global Youth Tour of Hebei丨A journey to vibrant industrial city — Tangshan

SHIJIAZHUANG, China, Dec. 13, 2023 /PRNewswire/ — This is a report from…

Henan Redefines Itself by Gaining an Edge in 5G

ZHENGZHOU, China, Dec. 13, 2023 /PRNewswire/ — A report from Science and…

Xinhua Silk Road: Cross-sector cooperation brings new vitality to Dehua white porcelain

BEIJING, Dec. 13, 2023 /PRNewswire/ — Recently, Jean-Charles Pigeau Studio held the inauguration…

New Book by Cheung Kong Graduate School of Business Shows How Chinese Companies are Transforming Global Business Through Digitalization and Innovation

BEIJING, Dec. 13, 2023 /PRNewswire/ — In a stride toward unraveling the dynamic…

Eaton partners with M-Link System to strengthen its Malaysia channel partnership network

KUALA LUMPUR, Malaysia, Dec. 13, 2023 /PRNewswire/ — Intelligent power management company…

Experience A Sparkling Festive Vacation With “Seasonal Wonders” On Vietnam’s Central Coast At Hoiana Resort & Golf

Vietnam’s premier beachfront integrated resort unveils a full calendar of uplifting activities…

Live from ASH 2023 | Results from Chinese Studies of Olverembatinib Presented in Oral Report at the ASH Annual Meeting for the Sixth Consecutive Year, Including Data Showing Promising Efficacy in Patients with TKI-Resistant and/or Intolerant CML-CP

SUZHOU, China and ROCKVILLE, Md., Dec. 13, 2023 /PRNewswire/ — Ascentage Pharma…